Interaction of onset and duration of diabetes on the percent of GAD and IA-2 antibody-positive subjects in the type 1 diabetes genetics consortium database

Diabetes Care

Volumn 34, Issue 4, 2011, Pages 988-993

  Tridgell, David M ^a,b   Spiekerman, Charles ^c   Wang, Richard S ^c   Greenbaum, Carla J ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GAD ANTIBODY; INSULINOMA ANTIGEN 2 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ONSET AGE;

ADOLESCENT; ADULT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; YOUNG ADULT;

EID: 79956199420     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1903     Document Type: Article

References (19)

1. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007;104: 17040-17045 (Pubitemid 350210987)
2. Zanone MM, Catalfamo E, Pietropaolo SL, et al. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual betacell function and glycemic control in young type 1 diabetic patients. Metabolism 2003;52:25-29
3. Notkins AL, Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 2001;108:1247-1252 (Pubitemid 33107747)
4. Hermitte L, Atlan-Gepner C, Mattei C, et al. Diverging evolution of anti-GAD and anti-IA-2 antibodies in long-standing diabetes mellitus as a function of age at onset: no association with complications. Diabet Med 1998;15:586-591 (Pubitemid 28319941)
5. Graham J, Hagopian WA, KockumI, et al.; Diabetes Incidence in Sweden Study Group; Swedish Childhood Diabetes Study Group. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002;51:1346-1355
6. Falorni A, Grubin CE, Takei I, et al. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994;19:113-125
7. Genovese S, Bonfanti R, Bazzigaluppi E, et al. Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia 1996;39:1223-1226
8. Knip M, Kukko M, Kulmala P, et al. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes. Am J Med Genet 2002;115:48-54 (Pubitemid 34650722)
9. Savola K, Bonifacio E, Sabbah E, et al.; Childhood Diabetes in Finland Study Group. IA-2 antibodies - a sensitive marker of IDDM with clinical onset in childhood and adolescence. Diabetologia 1998;41: 424-429
10. Qu HQ, Polychronakos C. The effect of the MHC locus on autoantibodies in type 1 diabetes. J Med Genet 2009;46: 469-471
11. Rich SS, Concannon P, Erlich H, et al. The Type 1 Diabetes Genetics Consortium. Ann N Y Acad Sci 2006;1079:1-8 (Pubitemid 44968694)
12. Yu L, Rewers M, Gianani R, et al. Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 1996;81:4264-4267 (Pubitemid 26412027)
13. Friedman JH. A Variable Span Scatterplot Smoother. Laboratory for Computational Statistics, 1984 (Stanford University Tech. Rep. No. 5), Stanford University, Stanford, CA
14. R Foundation for Statistical Computing and R Foundation for Statistical Computing. R: a language and environment for statistical computing [Internet], 2010. Vienna. Available from http://www.R-project.org. Accessed 1 June 2010
15. Kawasaki E, Takino H, Yano M, et al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994;43: 80-86
16. Hagopian WA, Sanjeevi CB, Kockum I, et al. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995;95:1505-1511
17. Palmer JP. C-peptide in the natural history of type 1 diabetes. Diabetes Metab Res Rev 2009;25:325-328
18. Gilliam LK, Pihoker C, Ellard S, et al. Unrecognized maturity-onset diabetes of the young (MODY) due to HNF1-alpha mutations in the SEARCH for Diabetes in Youth Study. Diabetes 2007;56(Suppl. 1): A74
19. Ellard S, Bellanné-Chantelot C, Hattersley AT; European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008;51: 546-553